Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carl A Gregory

Showing results (51-60 of 58) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 58 results.
British Journal of Cancer|March 12, 2022
Morpholino-driven blockade of Dkk-1 in osteosarcoma inhibits bone damage and tumour expansion by multiple mechanismsSimin Pan, Michael Cesarek, Carla Godoy, et al.
Cell Death & Disease|November 28, 2018
Three-dimensional in vitro modeling of malignant bone disease recapitulates experimentally accessible mechanisms of osteoinhibitionEoin P McNeill, Robert W Reese, Abishek Tondon, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 31, 2014
MSCs derived from iPSCs with a modified protocol are tumor-tropic but have much less potential to promote tumors than bone marrow MSCsQingguo Zhao, Carl A Gregory, Ryang Hwa Lee, et al.
Science Advances|November 10, 2023
<i>TWIST1</i> and <i>TSG6</i> are coordinately regulated and function as potency biomarkers in human MSCsRyang Hwa Lee, Siddaraju V Boregowda, Taeko Shigemoto-Kuroda, et al.
Cytotherapy|November 15, 2016
Comparison of the anti-inflammatory effects of induced pluripotent stem cell-derived and bone marrow-derived mesenchymal stromal cells in a murine model of corneal injuryYoung In Yun, Se Yeon Park, Hyun Ju Lee, et al.
Nature Communications|June 17, 2020
Characterization of a pluripotent stem cell-derived matrix with powerful osteoregenerative capabilitiesEoin P McNeill, Suzanne Zeitouni, Simin Pan, et al.
Cytotherapy|February 16, 2024
Scalable manufacture of therapeutic mesenchymal stromal cell products on customizable microcarriers in vertical wheel bioreactors that improve direct visualization, product harvest, and costAndrew Haskell, Berkley P White, Robert E Rogers, et al.
Stem Cells Translational Medicine|September 10, 2021
A scalable system for generation of mesenchymal stem cells derived from induced pluripotent cells employing bioreactors and degradable microcarriersRobert E Rogers, Andrew Haskell, Berkley P White, et al.
Pageof 6

Showing results (51-60 of 58) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 58 results.
British Journal of Cancer|March 12, 2022
Morpholino-driven blockade of Dkk-1 in osteosarcoma inhibits bone damage and tumour expansion by multiple mechanismsSimin Pan, Michael Cesarek, Carla Godoy, et al.
Cell Death & Disease|November 28, 2018
Three-dimensional in vitro modeling of malignant bone disease recapitulates experimentally accessible mechanisms of osteoinhibitionEoin P McNeill, Robert W Reese, Abishek Tondon, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 31, 2014
MSCs derived from iPSCs with a modified protocol are tumor-tropic but have much less potential to promote tumors than bone marrow MSCsQingguo Zhao, Carl A Gregory, Ryang Hwa Lee, et al.
Science Advances|November 10, 2023
<i>TWIST1</i> and <i>TSG6</i> are coordinately regulated and function as potency biomarkers in human MSCsRyang Hwa Lee, Siddaraju V Boregowda, Taeko Shigemoto-Kuroda, et al.
Cytotherapy|November 15, 2016
Comparison of the anti-inflammatory effects of induced pluripotent stem cell-derived and bone marrow-derived mesenchymal stromal cells in a murine model of corneal injuryYoung In Yun, Se Yeon Park, Hyun Ju Lee, et al.
Nature Communications|June 17, 2020
Characterization of a pluripotent stem cell-derived matrix with powerful osteoregenerative capabilitiesEoin P McNeill, Suzanne Zeitouni, Simin Pan, et al.
Cytotherapy|February 16, 2024
Scalable manufacture of therapeutic mesenchymal stromal cell products on customizable microcarriers in vertical wheel bioreactors that improve direct visualization, product harvest, and costAndrew Haskell, Berkley P White, Robert E Rogers, et al.
Stem Cells Translational Medicine|September 10, 2021
A scalable system for generation of mesenchymal stem cells derived from induced pluripotent cells employing bioreactors and degradable microcarriersRobert E Rogers, Andrew Haskell, Berkley P White, et al.
Pageof 6